The Valley Desk

NCT03906331 · Expanded access

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

Overall registry status Approved for marketing

Conditions Breast Cancer, Colon Cancer, Medullary Thyroid Cancer, Non Small Cell Lung Cancer, Other Solid Tumors With Evidence of Activating RET Alteration, Pancreatic Cancer, Papillary Thyroid Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov